Fwd: Merck Serono seeks EU approval for Erbitux for lung cancer (PharmaBiz)

---------- Forwarded message ----------
From: Yahoo! News Search Results for lung cancer <rssfwd@rssfwd.com>
Date: Sat, Sep 13, 2008 at 8:06 PM
Subject: Merck Serono seeks EU approval for Erbitux for lung cancer (PharmaBiz)
To: mesothelioma77@gmail.com


Merck Serono has submitted an application to the European Medicines Agency (EMEA) to license Erbitux (cetuximab) for the 1st-line treatment of epidermal growth factor receptor (EGFR) expressing, advanced or metastatic non-small cell lung cancer (NSCLC).

Fri, 12 Sep 2008 05:45:08 GMT

___
Source: http://us.rd.yahoo.com/dailynews/rss/search/lung+cancer/SIG=120d48v87/*http%3A//www.pharmabiz.com/article/detnews.asp?articleid=46036
--
 ~
Powered by [4]RssFwd, a service of [5]Blue Sky Factory, Inc